CALA Calithera Biosciences Inc.

Calithera Biosciences Announces Update on Complete Liquidation and Dissolution

Calithera Biosciences Announces Update on Complete Liquidation and Dissolution

Cancels Special Meeting of Stockholders

SOUTH SAN FRANCISCO, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: “CALA”). Calithera Biosciences, Inc. (the “Company”) announced that it was unable to achieve a quorum of stockholders at its special meeting of stockholders scheduled to be held on June 29, 2023 (the “Special Meeting”), for the purpose of approving the Company’s Plan of Complete Liquidation and Dissolution. In January 2023, the Company announced its intention to commence an orderly wind down of the Company’s business and operations. After consulting with its proxy solicitation advisors, the Company concluded that further attempts to solicit proxies for the Special Meeting would in all likelihood not allow it to achieve a quorum, and as a result has cancelled the Special Meeting.

CONTACT:

Stephanie Wong



650.870.1063



EN
29/06/2023

Underlying

CALACalithera Biosciences Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Calithera Biosciences Inc.

 PRESS RELEASE
Free
CALA Calithera Biosc...

Calithera Biosciences Announces Update on Complete Liquidation and Dis...

Calithera Biosciences Announces Update on Complete Liquidation and Dissolution Cancels Special Meeting of Stockholders SOUTH SAN FRANCISCO, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: “CALA”). Calithera Biosciences, Inc. (the “Company”) announced that it was unable to achieve a quorum of stockholders at its special meeting of stockholders scheduled to be held on June 29, 2023 (the “Special Meeting”), for the purpose of approving the Company’s Plan of Complete Liquidation and Dissolution. In January 2023, the Company announced its intention to commence an ...

June 29, 2023 1 EN
 PRESS RELEASE
Free
CALA Calithera Biosc...

Calithera Biosciences Announces Update on Complete Liquidation and Dis...

Calithera Biosciences Announces Update on Complete Liquidation and Dissolution Special Meeting to be Held on or about June 29, 2023 with a Record Date of May 25, 2023 SOUTH SAN FRANCISCO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: CALA) (the “Company”) announced that it intends to hold a special meeting of stockholders on or about June 29, 2023 (the “Special Meeting”),  for the purpose of approving the Company’s Plan of Complete Liquidation and Dissolution (the “Plan of Dissolution”).  In January 2023, the Company announced its intention to commence an or...

May 19, 2023 1 EN
Free Trial
CALA Calithera Biosc...

Calithera Biosciences Inc: 1 director

A director at Calithera Biosciences Inc sold 121,333 shares at 0.386USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

CALA CALITHERA BIOSCIENCES INC.
02/01/23 February 1, 2023 1 EN
 PRESS RELEASE
Free
CALA Calithera Biosc...

Calithera Biosciences Announces Board Approval of Complete Liquidation...

Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution SOUTH SAN FRANCISCO, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), today announced that its Board of Directors has determined, after extensive consideration of potential strategic alternatives, that it is in the best interests of its shareholders to dissolve the Company and liquidate its assets, following an orderly wind down of the company’s operations. In order to reduce costs and in connection with the planned dissolution, Calithera is discontinuing all clinica...

January 9, 2023 1 EN
 PRESS RELEASE
Free
CALA Calithera Biosc...

Calithera Biosciences Reports Third Quarter 2022 Financial Results and...

Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update -- Conference Call and Webcast Scheduled for 5:00 p.m. ET on Monday, November 14, 2022 -- SOUTH SAN FRANCISCO, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced its financial results for the third quarter ended September 30, 2022. “Earlier in the fourth quarter, we were very pleased to announce that we received FDA Fast Track designation for sapanisertib. This designation facilitates mo...

November 14, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch